SCHEMBL22985907

SCHEMBL22985907

CSc1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCC(N4CCCCC4)CC3)cc2OC(C)C)nc2c1NCN2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK7 Q13164 5/20 0.49
▸ LRRK2 Q5S007 15/20 0.44
▸ BRD4 O60885 3/20 0.44
▸ BRDT Q58F21 2/20 0.44
▸ DCLK1 O15075 2/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CHRM5 P08912 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ MBTD1 Q05BQ5 1/20 0.40
▸ TP53BP1 Q12888 1/20 0.40
▸ L3MBTL4 Q8NA19 1/20 0.40
▸ L3MBTL3 Q96JM7 1/20 0.40
▸ PHF20 Q9BVI0 1/20 0.40
▸ MORF4L1 Q9UBU8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985881 0.90 MAPK7 (0.53) MAPK7LRRK2BRD4BRDTDCLK1
SCHEMBL18018898 0.76 MAPK7 (0.48) MAPK7LRRK2BRD4BRDTDCLK1
SCHEMBL22985860 0.75 LRRK2 (0.53) MAPK7LRRK2BRD4BRDTDCLK1
SCHEMBL4052463 0.75 ALK (0.48) MAPK7LRRK2
SCHEMBL4048691 0.74 ALK (0.55) MAPK7LRRK2DCLK1KCNH2
SCHEMBL18018896 0.70 ALK (0.53) MAPK7LRRK2BRD4BRDTDCLK1
SCHEMBL19921183 0.70 LRRK2 (0.54) MAPK7LRRK2BRD4BRDTDCLK1
SCHEMBL22985912 0.70 LRRK2 (0.72) LRRK2
SCHEMBL4047900 0.69 FES (0.66) MAPK7LRRK2DCLK1KCNH2
SCHEMBL18018798 0.69 TTK (0.54) MAPK7LRRK2BRD4BRDTDCLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778605-A2 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 — — EP disclosed
EP-3778604-A1 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 — — EP disclosed
Send feedback